US › Healthcare

Journey Medical Corp (DERM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$6.40-1.08%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$16.0M
Revenue YoY
+21.5%
Net profit
$-2.2M
Profit YoY
+45.2%
EPS
$-0.08
EPS estimate
$-0.09
Net margin
-14.0%

EPS came in at -0.08 against a street estimate of -0.09 — a beat of 11.1%.

Key statistics

Market cap
$175.4M
Forward P/E
212.8
P/B
5.69
Book value
$1.13
EPS (TTM)
$-0.37
52-week high
$9.55
52-week low
$4.31
50-day MA
$6.51
200-day MA
$7.07
Beta
1.07

Analyst view

Analysts rate Journey Medical Corp a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $13.50.

Shareholding

Insiders
32.77%
Institutions
59.09%

Largest institutional holders

FundStake
Wasatch Advisors LP10.45%
TANG CAPITAL MANAGEMENT LLC5.89%
Vanguard Capital Management, LLC3.96%
BlackRock Inc3.56%
Opaleye Management Inc3.51%
J. Goldman & Co LP1.83%
Pale Fire Capital SE1.76%
Geode Capital Management, LLC1.69%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Journey Medical Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.